financetom
Technology
financetom
/
Technology
/
Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit -- Hagens Berman
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit -- Hagens Berman
Sep 28, 2025 5:48 PM

SAN FRANCISCO, Sept. 26, 2025 (GLOBE NEWSWIRE) -- A new class action lawsuit is targeting enterprise AI software company C3.ai ( AI ) and its senior leadership, alleging they misled investors about the company's financial health and growth prospects. The suit, filed in the U.S. District Court for the Northern District of California, claims that C3.ai ( AI ) and certain executives violated the Securities Exchange Act of 1934.

The firm urges investors in C3.ai ( AI ) who suffered significant losses to submit your losses now.

Class Period: Feb. 26, 2025Aug. 8, 2025
Lead Plaintiff Deadline: Oct. 21, 2025
Visit: www.hbsslaw.com/investor-fraud/ai
Contact the Firm Now:
[email protected]
  844-916-0895

C3.ai, Inc. ( AI ) Securities Class Action:

According to the complaint, filed under the caption Liggett v. C3.ai, Inc. ( AI ), the company projected an overly optimistic picture of its revenue and growth potential. The lawsuit alleges that these projections downplayed the significant risk posed by CEO Thomas M. Siebel’s health issues. The plaintiffs contend that C3.ai's ( AI ) public statements on growth and profitability were "unrealistic" and depended too heavily on the health and performance of its chief executive.

The case focuses on a significant drop in stock price that followed C3.ai's ( AI ) financial announcement on August 8, 2025. On that date, the company disclosed preliminary first-quarter results that fell short of expectations and lowered its revenue guidance for the full fiscal year. C3.ai ( AI ) attributed these disappointing results to "reorganization with new leadership" and Siebel's health problems. Following this news, the stock price reportedly plummeted by more than 25%.

The lawsuit seeks to represent investors who purchased or acquired C3.ai ( AI ) securities during the specified class period. Investors who suffered substantial losses and are interested in serving as a lead plaintiff must file a motion with the court no later than October 21, 2025.

“We’re focused on whether C3.ai’s public statements were misleading in their failure to fully disclose how CEO Thomas M. Siebel’s health was affecting the company’s ability to close deals and meet financial targets,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in C3.ai ( AI ) and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to frequently asked questions about the C3.ai ( AI ) case and our investigation, read more »

Whistleblowers: Persons with non-public information regarding C3.ai ( AI ) should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:

Reed Kathrein, 844-916-0895

Image: https://www.globenewswire.com/newsroom/ti?nf=OTUzNTk5MSM3MTY3NDMxIzIwMTg1MzI=

Image: https://ml.globenewswire.com/media/ODk3YTkyNTAtYmExMC00OTNmLThhMWUtNTM2NTgwN2I5YjAyLTEwMzAxMDUtMjAyNS0wOS0yNi1lbg==/tiny/Hagens-Berman-Sobol-Shapiro-LL.png Image: Primary Logo

Source: Hagens Berman Sobol Shapiro LLP

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lincoln Educational Servs Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Lincoln Educational Servs Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Mar 26, 2025
In the preceding three months, 4 analysts have released ratings for Lincoln Educational Servs , presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 0...
J&J Drug Combo Outperforms Leading Lung Cancer Treatment In Survival Study
J&J Drug Combo Outperforms Leading Lung Cancer Treatment In Survival Study
Mar 26, 2025
Johnson & Johnson ( JNJ ) announced results for the gold standard endpoint in cancer treatment of overall survival (OS) from the Phase 3 MARIPOSA study. Head-to-head comparison data versus AstraZeneca Plc ( AZN )‘s Tagrisso (osimertinib) showed Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) significantly extended OS in the first-line treatment for locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal...
5 Analysts Assess Guidewire Software: What You Need To Know
5 Analysts Assess Guidewire Software: What You Need To Know
Mar 26, 2025
In the preceding three months, 5 analysts have released ratings for Guidewire Software ( GWRE ) , presenting a wide array of perspectives from bullish to bearish. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic...
Expert Outlook: Vontier Through The Eyes Of 5 Analysts
Expert Outlook: Vontier Through The Eyes Of 5 Analysts
Mar 26, 2025
Across the recent three months, 5 analysts have shared their insights on Vontier ( VNT ) , expressing a variety of opinions spanning from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1...
Copyright 2023-2026 - www.financetom.com All Rights Reserved